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Summary.-Dose-response curves have been obtained for the response of EMT6
mouse tumour cells in vitro to adriamycin, actinomycin D, nitrogen mustard, BCNU
and CCNU. The experiments have been carried out with exponentially growing cells
and with cells in early and late plateau phase. The results are discussed with par-
ticular reference to discrepancies with the results obtained by other workers in
similar systems.
THERE HAS been considerable recent
interest in the radiation and drug response
of cultured mammalian cells in the plat-
eau phase of growth. This interest is
based on the fact that certain similarities
exist between the kinetics ofplateau phase
cultures and the kinetics of experimental
solid tumours (Hahn and Little,
1-972).
We have recently described (Twenty-
man et al., 1975) changes in kinetics which
occur during the life history of monolayer
ctultures of EMT6 mouse tumour cells.
During exponential growth the pulse
3HTdR labelling index is about 55%0 and
there is no cell loss. For the first 4 days
after attainment of plateau cell numbers,
the labelling index is about 25% and cell
loss is 20% per day. After 4 days of
plateau phase, however, the labelling
index falls to less than 20% and there is
virtually no cell loss. Our studies of
the cytotoxic drug, bleomycin, have shown
(Twentyman and Bleehen, 1973, 1975)
that in early plateau phase the sensitivity
is reduced from that shown by exponent-
ially growing cells. In late plateau phase,
however, the sensitivity increases again
and becomes greater than that ofexponen-
tial phase cells. In this paper we report
results obtained in exponential, early
plateau and late plateau phases for 5 other
cVtotoxic drugs.
MATERIALS AND METHODS
Full details of the cell line and ofthe drug
response assay have been described pre-
viously (Twentyman and Bleehen, 1975).
Briefly, 105 EMT6 mouse tumour cells were
inoculated on Day 0 into Falcon tissue culture
flasks containing 5 ml of Eagle's medium
supplemented with 20% calf serum. Change
of medium was carried out daily from Day 2.
Drugs were added directly to the growth
medium approximately 24 h aftertheprevious
medium change. At the end of the drug
exposure period, the medium was removed,
the monolayer was rinsed with fresh medium
and cells were then trypsinized from the
surface. After resuspension, counting and
diluting, the cells were plated into plastic
Petri dishes and incubated for 10 days. At
the end of this period the dishes were fixed
and stained and then colonies containing
more than 50 cells were counted.
The drugs used in the current series of
experiments are shown in Table I. All
drugs were added in a volume of between
0-04 and 0-2 ml. As a control for the alco-
hol solvent used for BCNU and CCNU, it
was established in a preliminary experiment
thatthe addition of 0-2 ml of absolute metha-
nol to cultures for 1 h had no effect on
cell survival.
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TABLE I. (Cytotoxic Agents Studied
Drug name
Adriamycin
(ADM)
Actiniomvcin D
(Act D)
MNustine hydro-
chloride
(HN2)
1.3 Bis
(2-Chloro-
ethyl) -1-
nitrosourea
(BCNU)
1-(2-Chloro-
ethyl)-3-
cyclohexyl 1-
nitrosol-irea
(CCNU)
Source
Pharmitalia
(U. K.) Ltd
Barnet, Englanid
Merck, Sharpe &
Dohme, Rahway
N.J., U.S.A.
Boots,
Nottingham
England
U. S. National
Cancer Inst.
U. S. National
Canieer Inst.
TABLE II.- (ell Kinetic Parameters of EMT6/M/CC (,Cultures
Day Designatioin
2 Exponential
5-6 Early plateau
14-15 Late plateau
95% conifidlence limits are shown.
Pulse3HTdIR
labelling
index
55-60
25
<1
Dose response curves for the various
drugs were obtained for cells at 2 days
(exponential), 5-6 days (early plateau) or
14-15 days (late plateau) after inoculation
of the flasks.
RESULTS
Kinetic parameters (taken from
Twentyman et al., 1975) for EMT6/M/CC
cells at the various phases used in this
series are shown in Table II together with
mean values of plating efficiency for the
current series of experiments.
The dose-response curves for the vari-
ous drugs studied are shown in Fig. 1-5.
Each point represents the surviving
fraction estimated from the mean colony
count on 4 replicate dishes. The errors
associated with individual determinations
were small compared with the spread of
results between separate determinations.
ADMI (Fig. 1).-For exponential phase
cells the dose-response curve falls rapidly
Cell cycle
time
(h)
11-12
32-40
Plating
Cell loss/day efficiency
0 99+4-6
,20% 91±5 5
11.12% 68 9-7
to reach a surviving fraction of about
10-3 at a dose of 2 pig/ml. At higher
doses, the fall is less steep. Both early
and late plateau phase cells are much
less sensitive, with the surviving fraction
still being in excess of 10% at a dose of
6 plg/ml.
ActD(Fig.2).-Thedose-response curve
for exponential phase cells is concave
upwards, falling to a surviving fraction
of 10% at 2-5 /ig/ml and 2% at 6X5 ,ug/ml.
For early and late plateau phase cells the
dose-response curve is less steep, reaching
20%survivingfraction at a doseof6,ug/ml.
HN2 (Fig. 3). For exponential phase
cells, the dose-response curvefallsvirtually
exponentially to a surviving fraction of
10-3 at 1 5 ,ug/ml. The curves forplateau
phase cells, however, both have a signifi-
cant intercept on the dose axis for 1000%
survival. In early plateau the shoulder
extends to about a dose of 1 ,ig/ml and
the curve then becomes exponential,
Added in
0 *04-0 2ml
of
M\fe(dium
Medium
Medium
Absoltute
methanol
Absoltute
methanol
Exposutre
time used
I h
1 h
15 mir
I h
I h
418CHANGES IN SENSITIVITY TO CYTOTOXIC AGENTS
i0
A\
--
A _-
A\
-
_
\A A
0 A A
0
40
0
0
S
c 0
L._
._
v)
10-2
A
A
0
0
0
0 *
.
0 1 2 3 4 5 6 7 8
Act D(,pg/mi)
10-
0
0 1 2 3 4
ADM (,ug/mI)
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plateau phase cells, Elate plateau
phase cells.
reaching survivingfraction of 10-3between
4 and 5 /igfml. In late plateau the initial
shoulder is similar to that in early plateau
but the exponential fall is less steep,
reaching surviving fraction of 10-2 at
about 5-5 pig/ml.
BCNU (Fig. 4). The results for all
3 phases are similar, although there is
considerable spread among individual
determinations. The points can best be
fitted by a curve with an initial shoulder
region extending to a dose of 5 pgfml and
a subsequent fall which is approximately
exponential.
CCNU (Fig. 5).-The results for all
3 phases are again similar and may be
fitted by a curve with an initial shoulder
region extending to a dose of about 2-5
/tg/ml and a subsequent exponential fall.
FI(,.r2.Change ofstrvivingfraction of E IT6
cells with (lose of actinomycin ]). 0
exponential phase cells,
- - early
plateau phase cells, - late plateau
phase cells.
5 6
DISCUSSION
ADMll
The curve which we have obtained for
exponentially growing cells is very similar
to that which has been described by
Barranco and Novak (1974) for Chinese
hamster ovary cells exposed to this agent.
These authors, however, observed a rather
different response in unfed plateau phase
cultures than we have obtained in our
system. Whereas there is no evidence
in our cell system for a biphasic response,
Barranco and Novak observed an initial
fall to a surviving fraction of 15oo at
2 ,g/ml and a slower fall to 8% at 6 ,Ig/ml.
This difference isdifficult to account for, as
there is considerably more proliferation
in our early plateau phase cultures than
in the unfed cultures used by these other
workers.
The available data on the relative
response to ADAI of cells in different
parts of the cell cycle (Barranco et al.,
1973b; Drewinko and Gottlieb, 1973) are
conflicting and therefore do niot help in
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the analysis of our results. Our early
observation on the response to ADM of
the EMT6 solid tumour in the mouse
treated in vivo and assayed, by cloning
in vitro, suggest that there is little cell kil-
ling even for large single doses of this
agent. This would perhaps support our
observation on EMT6 cells in plateau
phase culture.
Act D
In the various published studies on
proliferation dependence of cytotoxic
drugs, Act D has always shown some
dependence on proliferation, but much
less than that seen with manyotheragents.
This applies to the original comparison of
normal arnd lymphoma CFU in the marrow
FIcG. 4.-Change ofsurviving fraction ofEMT6
cells with dose ofBCNU. * expo-
nential phase cells, - - - A early plateau
phase cells, * [late plateau phase
cells.
(Bruce, Meeker and Valeriote, 1966), a
comparison of repopulating and maturing
cells in the erythroid system (Twentyman
and Blackett, 1970), confluent and cycling
embryonic hamster cells (Thatcher and
Walker, 1969) and proliferating and non-
proliferating lymphoid cells (Lin, 1973).
Our observations in this study are in
agreement with these findings in so far
that exponential phase cultures are more
sensitive than plateauphase cultures. We
did not, however, observe any differential
response between early and late plateau
despite the differences in kinetic para-
meters between these states.
The curve obtained for exponential
phase cells shows an initial rapid fall, fol-
lowed by a less steep fall with a slope
rather similar to that seen in early and
late plateau. This indicates that perhaps
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- 'A and appears to varv considerablv between
systems. Bruce et al. (1966) found that
rapidly proliferating lymphoma CFU
* were more sensitive than slowly prolifer-
*\ a ating normal haemopoietic CFU to
repeated doses of HN2, but no difference A was found for a single administration of
a \ @ the drug. In the mouse marrow, Blackett
and Adams (1972) and van Putten and
*AA Lelieveld (1971) have both shown that
CFU become more sensitive to HN2
when triggered into active proliferation
\v compared with their normal quiescent
\ state. In the lymphoid system, however,
* \ Lin (1973) showed only a slight difference
in response between proliferating and
O A non-proliferating cells. Using Chinese v hamster cells in culture Ray et al.,
A \ (1973) found no difference in response A
between exponential and plateau phase
cells.
a None of these workers have obtained
dose-response curves for HN2 having
- | | initial shoulders, a phenomenon shown -1
5 10 15 20 clearly in our results for plateau phase
CCNU (FWg/m ) cells. We are currently investigating
f . the situation regarding split-dose exposure
[Iswith dose ofCCNU f feTxpo- to HN2 in our plateau phase cells, in order ntial phase cells, - - - A early plateau to see whether the shoulder represents Lase cells, - * late plateau phase any ability to accumulate and repair sub- [is.
lethal damage.
15-20% of the cells in exponential phase
cultures have a sensitivity to Act D rather
similar to the plateau phase sensitivity.
Dataforother celltypes (Elkind, Sakamoto
and Kamper, 1968; Bienkowska, Dawson
and Peacock, 1973) suggest that cells
undergoing DNA synthesis are more
sensitive to Act D than are cells at other
parts of the cell cycle. This fact could
account, at least in part, for our findings
since about 5500 of cells in exponential
phase cultures are in the S phase, com-
pared with 25o/% and less than 200 in
early and late plateau respectively
(Twentyman et al., 1975).
HN2
The proliferation dependence of nitro-
gen mustard is a matter of some conjecture
BCNU
In their original investigation of the
relative response of exponential and plat-
eau phase Chinese hamster ovary cells to
BCNU, Barranco, Novak and Humphrey
(1973) found that exponential phase cells
were very muchless sensitive to this agent.
This finding was supported by the observa-
tions of Hageman, Schenken and Lescher
(1973) using a murine mastocytoma either
in vitro or as an ascites tumour in vivo.
However, Thatcher and Walker (1969)
found no difference in sensitivity to BCNU
as embryonic hamster cells move from
exponential into stationary phase. More
recently, Hahn, Gordon and Kurkjian
(1974) have pointed out that response to
BCNU in vitro is very dependent upon
the serum content of the medium to
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which the drug is added. The results of
Barranco et al. (1973a) and Hagemann
et al. (1973) both of whom added BCNU
directly to the existing medium in
which the cells were growing, could
therefore have been influenced by changes
in drug binding properties between expo-
nential and plateau phase medium. Never-
theless, Hahn et al. (1974) were able to
show that plateau phase cells are some-
what more sensitive to BCNU than
exponentially growing cells, even when
exposed to the drug without serum being
present.
Our results indicate little difference in
the sensitivity of exponential, early and
late plateau phase cells, even though we
carried out the experiments by adding the
drug directly to the growth medium.
This method in the study of Hahn et al.
(1974) greatly increased the differential
sensitivity between exponential and pla-
teau phase cells. Our experiments were
carried out over a period ofseveral months
and using several different serum batches,
and this could well explain the rather
wide spread seen between the results of
individual experiments. In no single
experiment, however, did we find expo-
nential phase cells to be considerably less
sensitive than cells in plateau phase. The
small differential between the exponential
and early plateau phases seen in our early
experiments (Twentyman and Bleehen,
1973), was not confirmed by these more
complete studies.
In the bone marrow, BCNU has been
found to have more effect against rapidly
proliferating colony-forming units (van
Putten, Lelieveld and Kram-Idsenga,
1972).
(cJCNU
MIostoftheremarkswhichwehavemade
concerning BCNU also apply to CCNU.
Barranco et at. (1975) have found this
agent to have less effect against expo-
nenitiallygrowing cells, even whenexposure
to the drug is carried out in a serum-free
medium. In the bone marrow, van
Putten et al. (1972) have again found more
effectofCCNUagainstrapidlythan against
slowly proliferating colony forming units.
The results which we have presented
in this paper are inseveralways conflicting
with results obtained in various other
plateau phase systems. We do not claim
that our results are in any way more cor-
rect than those of other workers, only
that they represent what happens for one
cell line under a very specific set of
conditions.
It should also be pointed out that, in
this type of study, the drug available per
cell is greater in exponential phase cul-
tures than in plateau phase for the same
concentration expressed in pig/ml. This
is intrinsic in the methodology and may
be a factorintheresultsobtained. Itdoes,
however, apply to the results of the other
workers as well as to our own results.
In our earlier report of the sensitivity
of exponential, early plateau and late
plateau phase cells to bleomycin (Twenty-
man and Bleehen, 1975), we analysed the
results of various workers in different cell
systems. WNe were unable to find any cor-
relationbetween bleomycin sensitivity and
either proliferative state or viability of the
populations. It is evident that if plateau
phase cells are to be useful as an in vitro
model of tumour cells in vivo, much more
mustbelearntofthefactors (e.g. membrane
permeability, repair mechanisms) which
determine the response to cytotoxic drugs
of cells in vitro. We are presently study-
ing some of these factors. On the other
hand, it may bethatthereisnosatisfactory
way of representing in vitro the complex
environmental situation existing in vivo.
In any case, in vitro tests at our present
stage of knoxvledge can act onlv as a very
preliminary guide to possible responses
which may or may not be confirmed by
subsequent work using experimental
tumour systems.
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grant from the Cancer Research Campaign
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